Boehringer Ingelheim first to break ranks in Brazilian cartel probe
Shutterstock/nitpicker
Drugmaker Boehringer Ingelheim has struck a settlement deal with Brazil’s competition watchdog, agreeing to pay a €4.35 million fine to end a probe into its role in a nearly three-decade-long conspiracy.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now